Mean Corpuscular Hemoglobin Modulates HbF/F‐Cell and Clinical Response to Gene Therapy and Hydroxyurea in Sickle Cell Disease

Documenti analoghi

• Normalization of Cerebral Hemodynamics After Gene Therapy in Adults With Sickle Cell Disease
  di: Akshay Sharma, et al.
  Pubblicazione: (2025)
• Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea (ESCORT‐HU) study
  di: Slimane Allali, et al.
  Pubblicazione: (2024)
• Targeting PIEZO1 ‐ TMEM16F Coupling to Mitigate Sickle Cell Disease Complications
  di: Pengfei Liang, et al.
  Pubblicazione: (2025)
• Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell Disease
  di: M. J. M. Traets, et al.
  Pubblicazione: (2025)
• Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview
  di: Adetola A. Kassim, et al.
  Pubblicazione: (2026)